Clinical Trial Update: rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study [Phase 3]

View source ↗

Summary

Pivotal Phase 3 study update for rhBMP-2/CRM/CD HORIZON spinal system in degenerative disc disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• rhBMP-2/CRM/CD HORIZON spinal system (rhBMP-2/CRM/CD HORIZON)

Snippet

Sponsor: Medtronic Spinal and Biologics | Conditions: Degenerative Disc Disease | Phase 3 | Status: COMPLETED